Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) EBIT (2022 - 2025)

Historic EBIT for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to $20.9 million.

  • Core Laboratories' EBIT rose 568.1% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.8 million, marking a year-over-year decrease of 704.34%. This contributed to the annual value of $58.6 million for FY2024, which is 716.69% up from last year.
  • Core Laboratories' EBIT amounted to $20.9 million in Q3 2025, which was up 568.1% from $15.3 million recorded in Q2 2025.
  • Over the past 5 years, Core Laboratories' EBIT peaked at $20.9 million during Q3 2025, and registered a low of $4.4 million during Q1 2025.
  • Over the past 4 years, Core Laboratories' median EBIT value was $14.7 million (recorded in 2022), while the average stood at $14.0 million.
  • Per our database at Business Quant, Core Laboratories' EBIT skyrocketed by 6225.54% in 2023 and then plummeted by 4846.58% in 2025.
  • Quarter analysis of 4 years shows Core Laboratories' EBIT stood at $15.6 million in 2022, then fell by 6.64% to $14.6 million in 2023, then dropped by 2.79% to $14.2 million in 2024, then soared by 47.65% to $20.9 million in 2025.
  • Its EBIT stands at $20.9 million for Q3 2025, versus $15.3 million for Q2 2025 and $4.4 million for Q1 2025.